trending Market Intelligence /marketintelligence/en/news-insights/trending/mv0rjj5om3jx-gptg73eva2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Spero names replacement for outgoing director


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Spero names replacement for outgoing director

Spero Therapeutics Inc., a clinical-stage biopharmaceutical company based in Cambridge, Mass., named John Pottage Jr. to its board.

Pottage is filling the position of outgoing director Casper Breum on the board of the company, which develops and commercializes treatments for multidrug-resistant bacterial infections.

Pottage is currently serving as senior vice president and chief scientific and medical officer of ViiV Healthcare UK Ltd.